NO933091L - Anvendelse av 1-aryl-3-(4-piperidyl)-indolderivater ved behandling av kognitive forstyrrelser - Google Patents

Anvendelse av 1-aryl-3-(4-piperidyl)-indolderivater ved behandling av kognitive forstyrrelser

Info

Publication number
NO933091L
NO933091L NO933091A NO933091A NO933091L NO 933091 L NO933091 L NO 933091L NO 933091 A NO933091 A NO 933091A NO 933091 A NO933091 A NO 933091A NO 933091 L NO933091 L NO 933091L
Authority
NO
Norway
Prior art keywords
piperidyl
aryl
treatment
cognitive disorders
indole derivatives
Prior art date
Application number
NO933091A
Other languages
English (en)
Other versions
NO933091D0 (no
NO307406B1 (no
Inventor
Jens Kristian Perregaard
Brenda Costall
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO933091D0 publication Critical patent/NO933091D0/no
Publication of NO933091L publication Critical patent/NO933091L/no
Publication of NO307406B1 publication Critical patent/NO307406B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Processing Of Meat And Fish (AREA)
NO933091A 1991-03-01 1993-08-31 Anvendelse av 1-aryl-3-(4-piperidyl)-indolderivater ved behandling av kognitive forstyrrelser NO307406B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK036291A DK36291D0 (da) 1991-03-01 1991-03-01 Anvendelse af piperidylsubstituerede indolderivater til behandling af kognitive lidelser
PCT/DK1992/000063 WO1992015303A1 (en) 1991-03-01 1992-02-28 Treatment of cognitive disorders

Publications (3)

Publication Number Publication Date
NO933091D0 NO933091D0 (no) 1993-08-31
NO933091L true NO933091L (no) 1993-11-01
NO307406B1 NO307406B1 (no) 2000-04-03

Family

ID=8092662

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933091A NO307406B1 (no) 1991-03-01 1993-08-31 Anvendelse av 1-aryl-3-(4-piperidyl)-indolderivater ved behandling av kognitive forstyrrelser

Country Status (17)

Country Link
US (1) US5444073A (no)
EP (1) EP0575429B1 (no)
JP (1) JP3108434B2 (no)
KR (1) KR0183424B1 (no)
AT (1) ATE131055T1 (no)
AU (1) AU663699B2 (no)
CA (1) CA2105385C (no)
CY (1) CY2083B1 (no)
DE (1) DE69206607T2 (no)
DK (2) DK36291D0 (no)
HK (1) HK1003560A1 (no)
IE (1) IE70600B1 (no)
IL (1) IL101102A (no)
NO (1) NO307406B1 (no)
NZ (1) NZ241800A (no)
WO (1) WO1992015303A1 (no)
ZA (1) ZA921462B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
US6489341B1 (en) 1999-06-02 2002-12-03 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
EP1535616B1 (en) 2002-08-22 2009-05-13 Dainippon Sumitomo Pharma Co., Ltd. Remedy for integration dysfunction syndrome
KR101113630B1 (ko) * 2003-06-23 2012-02-13 다이닛본 스미토모 세이야꾸 가부시끼가이샤 노인성 치매 치료제
US20070160537A1 (en) 2004-02-20 2007-07-12 Takeo Ishiyama In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia
US20070212412A1 (en) * 2005-09-08 2007-09-13 H. Lundbeck A/S Stable solid formulation of sertindole
TW200821296A (en) * 2006-06-01 2008-05-16 Lundbeck & Co As H Use of sertindole for the preventive treatment of suicidal behaviour
US8258139B2 (en) 2010-11-08 2012-09-04 Dainippon Sumitomo Pharma Co., Ltd. Method of treatment for mental disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48508A (en) * 1974-12-09 1979-10-31 Roussel Uclaf Pharmaceutical compositions comprising piperidylindole derivatives
FR2362628A1 (fr) * 1976-08-26 1978-03-24 Roussel Uclaf Nouveaux derives du piperidyl-indole et leurs sels, procede de preparation et application a titre de medicaments
SE8004129L (sv) * 1979-07-13 1981-01-14 Roussel Uclaf Nya tetrahydropyridin-4-yl-indolderivat samt salter derav, framstellning och anvendning derav sasom lekemedel samt kompositioner innehallande dessa foreningar
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8704572D0 (en) * 1987-02-26 1987-04-01 Lundbeck & Co As H Organic compounds
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater

Also Published As

Publication number Publication date
DK36291D0 (da) 1991-03-01
KR0183424B1 (ko) 1999-05-01
IE70600B1 (en) 1996-12-11
CY2083B1 (en) 1998-10-16
CA2105385C (en) 2000-08-15
HK1003560A1 (en) 1998-10-30
WO1992015303A1 (en) 1992-09-17
JP3108434B2 (ja) 2000-11-13
ATE131055T1 (de) 1995-12-15
IL101102A (en) 1996-03-31
DE69206607D1 (de) 1996-01-18
ZA921462B (en) 1992-11-25
NO933091D0 (no) 1993-08-31
IE920572A1 (en) 1992-09-09
DK0575429T3 (da) 1996-04-22
NO307406B1 (no) 2000-04-03
AU1370792A (en) 1992-10-06
AU663699B2 (en) 1995-10-19
JPH06504787A (ja) 1994-06-02
KR930702978A (ko) 1993-11-29
IL101102A0 (en) 1992-11-15
CA2105385A1 (en) 1992-09-02
NZ241800A (en) 1997-03-24
EP0575429A1 (en) 1993-12-29
EP0575429B1 (en) 1995-12-06
DE69206607T2 (de) 1996-05-15
US5444073A (en) 1995-08-22

Similar Documents

Publication Publication Date Title
NO974163D0 (no) Ester av 5-aminolevulinsyre som fotosensibiliserings-middel i fotokjemoterapi
DK275488D0 (da) Indolonderivater
RU93055870A (ru) Производные бифенила, способ их получения и фармацевтическая композиция для лечения гипертонии и сердечных заболеваний
EP0376899A3 (en) Use of L-carnitine derivatives for the manufacture of a medicament for the therapeutical treatment of peripheral neuropathies
NO307406B1 (no) Anvendelse av 1-aryl-3-(4-piperidyl)-indolderivater ved behandling av kognitive forstyrrelser
ES2053668T3 (es) Derivados de poliamina como agentes antineoplasicos.
ZA922910B (en) Heterocylic pharmaceutical compounds preparation and use
ES8103071A1 (es) Procedimiento de preparacion de nuevos derivados aminicos del benzotiazol
FR2458556B1 (no)
CA2289017A1 (en) The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
FI96308C (fi) Menetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinien ja niiden johdannaisten valmistamiseksi
MY133438A (en) Morpholinobenzamide salts
PT1082116E (pt) Utilizacao de derivados de 4-piperidinometanol no tratamento de desordens do neurodesenvolvimento
NO173783C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, kondenserte heterodykliske derivater av 1,2,3,4-tetrahydroakridiner
SE8302452D0 (sv) Method for treatment of senile dementia
NO974101L (no) Anvendelse av penciclovir for behandling av human herpes virus-8
US6541495B1 (en) Carboxylic acid derivatives as inhibitors of hyperproliferation diseases
KR940018387A (ko) 위장 장애와 궤양 유발이 현저히 감소된 케토롤락 유도체
NO961180L (no) Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees